Gough MJ - Search Results

1

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. Bateman AR, et al. Among authors: gough mj. Cancer Res. 2002 Nov 15;62(22):6566-78. Cancer Res. 2002. PMID: 12438252

2

Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Linardakis E, et al. Cancer Res. 2002 Oct 1;62(19):5495-504. Cancer Res. 2002. PMID: 12359759

3

Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells.

Bonnotte B, Gough M, Phan V, Ahmed A, Chong H, Martin F, Vile RG. Bonnotte B, et al. Cancer Res. 2003 May 1;63(9):2145-9. Cancer Res. 2003. PMID: 12727832

4

Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.

Crittenden M, Gough M, Chester J, Kottke T, Thompson J, Ruchatz A, Clackson T, Cosset FL, Chong H, Diaz RM, Harrington K, Alvarez Vallina L, Vile R. Crittenden M, et al. Cancer Res. 2003 Jun 15;63(12):3173-80. Cancer Res. 2003. PMID: 12810645

5

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines.

Phan V, Errington F, Cheong SC, Kottke T, Gough M, Altmann S, Brandenburger A, Emery S, Strome S, Bateman A, Bonnotte B, Melcher A, Vile R. Phan V, et al. Nat Med. 2003 Sep;9(9):1215-9. doi: 10.1038/nm923. Epub 2003 Aug 17. Nat Med. 2003. PMID: 12925849

6

Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity.

Crittenden M, Gough M, Harrington K, Olivier K, Thompson J, Vile RG. Crittenden M, et al. Cancer Res. 2003 Sep 1;63(17):5505-12. Cancer Res. 2003. PMID: 14500387

7

Macrophages orchestrate the immune response to tumor cell death.

Gough MJ, Melcher AA, Ahmed A, Crittenden MR, Riddle DS, Linardakis E, Ruchatz AN, Emiliusen LM, Vile RG. Gough MJ, et al. Cancer Res. 2001 Oct 1;61(19):7240-7. Cancer Res. 2001. PMID: 11585761

8

Intratumoral immunotherapy: using the tumour against itself.

Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ. Crittenden MR, et al. Among authors: gough mj. Immunology. 2005 Jan;114(1):11-22. doi: 10.1111/j.1365-2567.2004.02001.x. Immunology. 2005. PMID: 15606790 Free PMC article. Review.

9

Dendritic cells for the immunotherapy of cancer.

Melcher A, Bateman A, Harrington K, Ahmed A, Gough M, Vile R. Melcher A, et al. Clin Oncol (R Coll Radiol). 2002 Jun;14(3):185-92. doi: 10.1053/clon.2001.0038. Clin Oncol (R Coll Radiol). 2002. PMID: 12109820 Review. No abstract available.

10

A simple method to cure established tumors by inflammatory killing of normal cells.

Daniels GA, Sanchez-Perez L, Diaz RM, Kottke T, Thompson J, Lai M, Gough M, Karim M, Bushell A, Chong H, Melcher A, Harrington K, Vile RG. Daniels GA, et al. Nat Biotechnol. 2004 Sep;22(9):1125-32. doi: 10.1038/nbt1007. Epub 2004 Aug 1. Nat Biotechnol. 2004. PMID: 15300260 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters